{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T23:55:45Z","timestamp":1770076545135,"version":"3.49.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.critrevonc.2025.105047","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:02:20Z","timestamp":1764835340000},"page":"105047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\"THE ENDS IN THE BEGINNINGS\u201d age-related mechanisms of Telomere maintenance in pediatric and AYA-group Neuroblastoma."],"prefix":"10.1016","volume":"218","author":[{"given":"Ugo","family":"Rovigatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6419","key":"10.1016\/j.critrevonc.2025.105047_bib1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.aat6768","article-title":"A mechanistic classification of clinical phenotypes in neuroblastoma","volume":"362","author":"Ackermann","year":"2018","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105047_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081112","article-title":"How Do telomere abnormalities regulate the biology of neuroblastoma?","volume":"11","author":"Akter","year":"2021","journal-title":"Biomolecules"},{"issue":"7463","key":"10.1016\/j.critrevonc.2025.105047_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"7793","key":"10.1016\/j.critrevonc.2025.105047_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105047_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/gcc.22827","article-title":"Genomic coamplification of CDK4\/MDM2\/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients","volume":"59","author":"Amoroso","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105047_bib6","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/leu.2011.90","article-title":"The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia","volume":"25","author":"Balgobind","year":"2011","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105047_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neo.2014.05.012","article-title":"Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltration","volume":"16","author":"Berbegall","year":"2014","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105047_bib8","article-title":"Diagnostic implications of intrapatient genetic tumor heterogeneity","volume":"3","author":"Berbegall","year":"2016","journal-title":"Mol. Cell. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105047_bib9","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41416-018-0098-6","article-title":"Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study","volume":"118","author":"Berbegall","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"41","key":"10.1016\/j.critrevonc.2025.105047_bib10","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1002\/anie.201002387","article-title":"Telomeres and telomerase: the means to the end (Nobel Lecture)","volume":"49","author":"Blackburn","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105047_bib11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/1097-0142(19950901)76:5<890::AID-CNCR2820760525>3.0.CO;2-X","article-title":"Indolent course of advanced neuroblastoma in children older than 6 years at diagnosis","volume":"76","author":"Blatt","year":"1995","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.30050","article-title":"The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma10.1002\/ijc.30050","volume":"139","author":"Bogen","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib13","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-020-18987-4","article-title":"Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations","volume":"11","author":"Brady","year":"2020","journal-title":"Nat. Commun."},{"issue":"4653","key":"10.1016\/j.critrevonc.2025.105047_bib14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1126\/science.6719137","article-title":"Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage","volume":"224","author":"Brodeur","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2025.105047_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/nm1197-1271","article-title":"Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines","volume":"3","author":"Bryan","year":"1997","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105047_bib16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/genetics\/128.4.695","article-title":"Adaptive reversion of a frameshift mutation in Escherichia coli","volume":"128","author":"Cairns","year":"1991","journal-title":"Genetics"},{"key":"10.1016\/j.critrevonc.2025.105047_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/335142a0","article-title":"The origin of mutants","volume":"335","author":"Cairns","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2025.105047_bib18","article-title":"Translating the game: ribosomes as active players","author":"Calamita","year":"2020","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12094-010-0466-z","article-title":"Neuroblastoma in adolescents: genetic and clinical characterisation","volume":"12","author":"Castel","year":"2010","journal-title":"Clin. Transl. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105047_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrg2763","article-title":"Alternative lengthening of telomeres: models, mechanisms and implications","volume":"11","author":"Cesare","year":"2010","journal-title":"Nat. Rev. Genet."},{"issue":"10 AN - 22416102","key":"10.1016\/j.critrevonc.2025.105047_bib21","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2012.228","article-title":"Association of age at diagnosis and genetic mutations in patients with neuroblastoma LA - eng","volume":"307","author":"Cheung","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105047_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3526","article-title":"Neuroblastoma: developmental biology, cancer genomics and immunotherapy","volume":"13","author":"Cheung","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2025.105047_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"5 2","key":"10.1016\/j.critrevonc.2025.105047_bib24","first-page":"33","article-title":"G. Mendel's law concerning the behavior of progeny of varietal hybrids","volume":"35","author":"Correns","year":"1950","journal-title":"Genetics"},{"issue":"6217","key":"10.1016\/j.critrevonc.2025.105047_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1126\/science.347.6217.12","article-title":"The bad luck of cancer","volume":"347","author":"Couzin-Frankel","year":"2015","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105047_bib26","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.celrep.2017.05.087","article-title":"Extensive proliferation of human cancer cells with ever-shorter telomeres","volume":"19","author":"Dagg","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPH.0000000000000840","article-title":"TERT-mediated and ATRX-mediated Telomere Maintenance and Neuroblastoma","volume":"40","author":"Duan","year":"2018","journal-title":"J. Pediatr. Hematol. \/Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105047_bib28","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026567","article-title":"ATRX and DAXX: Mechanisms and Mutations","volume":"7","author":"Dyer","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.critrevonc.2025.105047_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3333","article-title":"Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations","volume":"47","author":"Eleveld","year":"2015","journal-title":"Nat. Genet"},{"key":"10.1016\/j.critrevonc.2025.105047_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-cancerbio-050216-121919","article-title":"Stress-induced mutagenesis: implications in cancer and drug resistance LA - eng","volume":"1","author":"Fitzgerald","year":"2017","journal-title":"Annu. Rev. Cancer Biol."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.105047_bib31","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1128\/JB.186.15.4846-4852.2004","article-title":"Adaptive mutation in Escherichia coli","volume":"186","author":"Foster","year":"2004","journal-title":"J. Bacteriol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib32","doi-asserted-by":"crossref","first-page":"22432","DOI":"10.1038\/s41598-020-78370-7","article-title":"Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance","volume":"10","author":"Fransson","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105047_bib33","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/cas.15363","article-title":"Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics","volume":"113","author":"van Gerven","year":"2022","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105047_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289084","article-title":"Two opposing gene expression patterns within ATRX aberrant neuroblastoma","volume":"18","author":"van Gerven","year":"2023","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105047_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1816","article-title":"Infection, immune responses and the aetiology of childhood leukaemia","volume":"6","author":"Greaves","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105047_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","article-title":"A causal mechanism for childhood acute lymphoblastic leukaemia","volume":"18","author":"Greaves","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2025.105047_bib37","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrc1164","article-title":"Origins of chromosome translocations in childhood leukaemia","volume":"3","author":"Greaves","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105047_bib38","doi-asserted-by":"crossref","first-page":"R178","DOI":"10.1016\/S0960-9822(98)70105-8","article-title":"Telomeres and senescence: The history, the experiment, the future","volume":"8","author":"Greider","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.critrevonc.2025.105047_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Groebner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2025.105047_bib40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ng.3899","article-title":"Neuroblastoma is composed of two super-enhancer-associated differentiation states","volume":"49","author":"van Groningen","year":"2017","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105047_bib41","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s41588-023-01395-x","article-title":"Clonal evolution during metastatic spread in high-risk neuroblastoma","volume":"55","author":"Gundem","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2025.105047_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(03)12681-5","article-title":"Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme","volume":"361","author":"Hakin-Smith","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2025.105047_bib43","doi-asserted-by":"crossref","unstructured":"Hayflick, L. and P.S. Moorhead, The serial cultivation of human diploid cell strains. 1961. 25: p. 585-621.","DOI":"10.1016\/0014-4827(61)90192-6"},{"key":"10.1016\/j.critrevonc.2025.105047_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"issue":"45","key":"10.1016\/j.critrevonc.2025.105047_bib45","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1523\/JNEUROSCI.1840-17.2017","article-title":"Epigenetic Etiology of Intellectual Disability","volume":"37","author":"Iwase","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.critrevonc.2025.105047_bib46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105047_bib47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4149\/neo_2021_210325N399","article-title":"Exploring the prognosis of neuroblastoma in adolescents and adults: a case series and literature review","volume":"69","author":"Jin","year":"2022","journal-title":"Neoplasma"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105047_bib48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41568-019-0169-x","article-title":"Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours","volume":"19","author":"Jones","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105047_bib49","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jpedsurg.2016.09.042","article-title":"Telomere biology including <em>TERT<\/em> rearrangements in neuroblastoma: a useful indicator for surgical treatments","volume":"51","author":"Kawashima","year":"2016","journal-title":"J. Pediatr. Surg."},{"issue":"5193","key":"10.1016\/j.critrevonc.2025.105047_bib50","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib51","first-page":"12","article-title":"Childhood leukaemia, nuclear sites, and population mixing","volume":"104","author":"Kinlen","year":"2011","journal-title":"Br. Med. J. BMJ"},{"key":"10.1016\/j.critrevonc.2025.105047_bib52","first-page":"2135","article-title":"Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma","volume":"4","author":"Kramer","year":"1998","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105047_bib53","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2019.03.001","article-title":"A Compendium of Mutational Signatures of Environmental Agents","volume":"177","author":"Kucab","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105047_bib54","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/cncr.10800","article-title":"Chronic neuroblastoma","volume":"95","author":"Kushner","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2025.105047_bib55","doi-asserted-by":"crossref","unstructured":"Larrosa, C., J. Mora, and N.-K. Cheung, Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2. 2023.","DOI":"10.3390\/cancers15143729"},{"issue":"5312","key":"10.1016\/j.critrevonc.2025.105047_bib56","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.276.5312.561","article-title":"Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase","volume":"276","author":"Lingner","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2025.105047_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/0092-8674(93)90234-H","article-title":"An alternative pathway for yeast telomere maintenance rescues est1\u00e2\u02c6\u2019 senescence","volume":"73","author":"Lundblad","year":"1993","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105047_bib58","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0092-8674(89)90132-3","article-title":"A mutant with a defect in telomere elongation leads to senescence in yeast","volume":"57","author":"Lundblad","year":"1989","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1056\/NEJMsb1502456","article-title":"Causality and chance in the development of cancer","volume":"373","author":"Luzzatto","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.105047_bib60","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1093\/nar\/gkz634","article-title":"DAXX in cancer: phenomena, processes, mechanisms and regulation10.1093\/nar\/gkz634","volume":"47","author":"Mahmud","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib61","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"7391","key":"10.1016\/j.critrevonc.2025.105047_bib62","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nature10910","article-title":"Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes","volume":"483","author":"Molenaar","year":"2012","journal-title":"NATURE"},{"key":"10.1016\/j.critrevonc.2025.105047_bib63","article-title":"Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project","volume":"61","author":"Mosse","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105047_bib64","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jjco\/hyx176","article-title":"Neuroblastoma10.1093\/jjco\/hyx176","volume":"48","author":"Nakagawara","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105047_bib65","unstructured":"nobelprize, \u3008http:\/\/www.nobelprize.org\/nobel_prizes\/medicine\/laureates\/2009\/Nobel2BlackburnGreiderSzostack\u3009. 2009, nobelprizeorg."},{"key":"10.1016\/j.critrevonc.2025.105047_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082228","article-title":"The chromatin remodeler ATRX: role and mechanism in biology and cancer","author":"Pang","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.105047_bib67","first-page":"6","article-title":"Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair","volume":"71","author":"Phillips","year":"2018","journal-title":"DNA Repair. edge Perspect. Genom. Maint. V."},{"key":"10.1016\/j.critrevonc.2025.105047_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/21.3.477","article-title":"The role of senescence and immortalization in carcinogenesis","volume":"21","author":"Reddel","year":"2000","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105047_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.19.00072","article-title":"Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in Neuroblastoma10.1200\/PO.19.00072","author":"Roderwieser","year":"2019","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105047_bib70","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/35080556","article-title":"Evolving responsively: adaptive mutation","volume":"2","author":"Rosenberg","year":"2001","journal-title":"Nat. Rev. Genet."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.105047_bib71","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1128\/JB.186.15.4838-4843.2004","article-title":"Adaptive point mutation and adaptive amplification pathways in the Escherichia coli Lac system: stress responses producing genetic change","volume":"186","author":"Rosenberg","year":"2004","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.critrevonc.2025.105047_bib72","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2020.11.044","article-title":"The glycosphingolipid GD2 as an effective but enigmatic target of passive immunotherapy in children with aggressive neuroblastoma (HR-NBL)","volume":"503","author":"Rovigatti","year":"2021","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105047_bib73","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3892\/wasj.2022.151","article-title":"Neuroblastoma in childhood and its potential viral involvement: A webinar by the Paediatric Virology Study Group","volume":"4","author":"Rovigatti","year":"2022","journal-title":"World Acad. Sci. J. World Acad. Sci. J."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105047_bib74","first-page":"195","article-title":"Isolation and initial characterization of a new virus: Micro-Foci inducing virus or MFV","volume":"315","author":"Rovigatti","year":"1992","journal-title":"C. R. Acad. Sci. III"},{"key":"10.1016\/j.critrevonc.2025.105047_bib75","series-title":"Intn. Conference Childhood Leukaemia. Section P1-18 pp I-IV, September 2004","article-title":"Preliminary Characterization of a New Type of Viruses Isolated from Paediatric Neuroblastoma and Non-Hodgkin\u2019s Lymphoma: potential Implications for Aetiology","author":"Rovigatti","year":"2004"},{"issue":"0","key":"10.1016\/j.critrevonc.2025.105047_bib76","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1016\/j.nmd.2012.10.018","article-title":"Chronic Fatigue Syndrome (CFS) and Cancer Related Fatigue (CRF): two \"fatigue\" syndromes with overlapping symptoms and possibly related aetiologies","volume":"3","author":"Rovigatti","year":"2012","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105047_bib77","article-title":"Cover page International Journal of Oncology","volume":"58","author":"Rovigatti","year":"2021","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib78","first-page":"1","article-title":"The Long Journey of cancer Modeling: Ubi Sumus ? Quo Vadimus ?","volume":"1","author":"Rovigatti","year":"2016","journal-title":"Mathe J. Cancer Sci."},{"key":"10.1016\/j.critrevonc.2025.105047_bib79","doi-asserted-by":"crossref","unstructured":"Rovigatti U. MFV Virus unduces MYCN DNA amplification and transforms benign neuroblastsinto cells tumorigenic in nude mice. in 18th International Congress of Biochemistry and Molecular Biology \"Beyond the Genome\". 2000. London, UK.","DOI":"10.1042\/bst028a225"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105047_bib80","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.critrevonc.2015.05.017","article-title":"Cancer modelling in the NGS era - Part I: Emerging technology and initial modelling","volume":"96","author":"Rovigatti","year":"2015","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.critrevonc.2025.105047_bib81","unstructured":"Rovigatti U. (2025). Paradigms and Paradoxes in Neuroblastoma: Implications for Cancer Modeling and Immunotherappy."},{"key":"10.1016\/j.critrevonc.2025.105047_bib82","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.54.0674","article-title":"Emergence of new ALK mutations at relapse of neuroblastoma","volume":"32","author":"Schleiermacher","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105047_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3349","article-title":"Mutational dynamics between primary and relapse neuroblastomas","volume":"47","author":"Schramm","year":"2015","journal-title":"Nat. Genet"},{"issue":"5931","key":"10.1016\/j.critrevonc.2025.105047_bib84","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/305245a0","article-title":"Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour","volume":"305","author":"Schwab","year":"1983","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.critrevonc.2025.105047_bib85","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJM198510313131802","article-title":"Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas","volume":"313","author":"Seeger","year":"1985","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib86","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/35036093","article-title":"Hayflick, his limit, and cellular ageing","volume":"1","author":"Shay","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105047_bib87","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","article-title":"Telomeres and telomerase: three decades of progress","volume":"20","author":"Shay","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib88","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41467-019-13824-9","article-title":"Genomic footprints of activated telomere maintenance mechanisms in cancer","volume":"11","author":"Sieverling","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105047_bib89","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00439-006-0146-9","article-title":"Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias","volume":"119","author":"Strick","year":"2006","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105047_bib90","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/ijc.31399","article-title":"Treatment and outcome of adult-onset neuroblastoma","volume":"143","author":"Suzuki","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"6331","key":"10.1016\/j.critrevonc.2025.105047_bib91","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.aaf9011","article-title":"Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention","volume":"355","author":"Tomasetti","year":"2017","journal-title":"Science"},{"issue":"6217","key":"10.1016\/j.critrevonc.2025.105047_bib92","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1260825","article-title":"Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti","year":"2015","journal-title":"Science"},{"issue":"5 2","key":"10.1016\/j.critrevonc.2025.105047_bib93","first-page":"42","article-title":"Concerning artificial crossing in Pisum sativum","volume":"35","author":"Tschermak","year":"1950","journal-title":"Genetics"},{"key":"10.1016\/j.critrevonc.2025.105047_bib94","doi-asserted-by":"crossref","unstructured":"Turi, Z., et al., Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging. Aging. 11(8): p. 2512-2540 doi: \u300810.18632\/aging101922\u3009.","DOI":"10.18632\/aging.101922"},{"key":"10.1016\/j.critrevonc.2025.105047_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3438","article-title":"TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors","volume":"47","author":"Valentijn","year":"2015","journal-title":"Nat. Genet"},{"key":"10.1016\/j.critrevonc.2025.105047_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092211","article-title":"The multiple facets of ATRX protein","author":"Valenzuela","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105047_bib97","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/onc.2010.15","article-title":"2009 Nobel prize in physiology or medicine: telomeres and telomerase","volume":"29","author":"Varela","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.105047_bib98","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-08-0099","article-title":"Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma","volume":"14","author":"Villa","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105047_bib99","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1438-8677.1900.tb04884.x","article-title":"11. Hugo de Vries: Das Spaltungsgesetz der Bastarde","volume":"18","author":"Vries","year":"1900","journal-title":"Ber. der Dtsch. Bot. Ges."},{"issue":"5 2","key":"10.1016\/j.critrevonc.2025.105047_bib100","first-page":"30","article-title":"Concerning the law of segregation of hybrids","volume":"35","author":"De Vries","year":"1950","journal-title":"Genetics"},{"issue":"94","key":"10.1016\/j.critrevonc.2025.105047_bib101","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/newbio239197a0","article-title":"Origin of concatemeric T7 DNA","volume":"239","author":"Watson","year":"1972","journal-title":"Nat. N. Biol."},{"issue":"6651","key":"10.1016\/j.critrevonc.2025.105047_bib102","first-page":"551","article-title":"The end-replication problem","volume":"389","author":"Wynford-Thomas","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105047_bib103","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41467-020-14682-6","article-title":"MYCN amplification and ATRX mutations are incompatible in neuroblastoma","volume":"11","author":"Zeineldin","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.105047_bib104","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.dnarep.2006.05.020","article-title":"Chromatin structural elements and chromosomal translocations in leukemia","volume":"5","author":"Zhang","year":"2006","journal-title":"DNA Repair (Amst. )"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825004354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825004354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:34:28Z","timestamp":1770035668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825004354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":104,"alternative-id":["S1040842825004354"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105047","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\"THE ENDS IN THE BEGINNINGS\u201d age-related mechanisms of Telomere maintenance in pediatric and AYA-group Neuroblastoma.","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105047"}}